
Meet Medrio Recap
How right-sized, efficient, and cost-effective trial technology solutions can get your devices to market faster. Intro A question we hear a lot from our medical
How right-sized, efficient, and cost-effective trial technology solutions can get your devices to market faster. Intro A question we hear a lot from our medical
A lot can go wrong in the lifecycle of an investigational product (IP). Medrio’s Randomized and Trial Supply Management (RTSM) expert, Ian Davison, shares proven
With the constant pressures to do more with less, it can be overwhelming for medical device and diagnostics (MDD) researchers to plan out clinical trials
What’s your top priority when selecting an RTSM solution? Is it a tool that helps you streamline operations to reduce exorbitant trial costs? Or perhaps
By all expert accounts, 2022 is the year that we can begin seeing the societal shift from late-stage pandemic to early-stage endemic as the world
It’s 2022—the world is embracing digitalization on a mass scale, yet 76% of healthcare organizations admit to printing their consent forms on paper. Why does the clinical trials
It’s 2022—over one hundred years have passed since the women’s suffrage movement; women make up more than half of the college-educated workforce; and the U.S. has our first female Vice President. But, many of us continue to ask, “Is that enough?” (Hint: the answer is a resounding NO!)
The clinical trials industry is buckling under the weight of continuously growing complexities. Developing an interconnected clinical trials ecosystem will be essential to minimizing the
The process of bringing a new treatment to market can be a long, arduous journey. On average, it takes ten years for a treatment to
Trial sites are a cornerstone of clinical research but are often overloaded with a myriad of complex, manual, and time-sensitive tasks. How can sites be
Orphan drug discoveries promise unprecedented opportunities, as well as challenges. Unfortunately, research in the rare disease space presents some of the highest hurdles in medicine
Protecting a patient’s personal health information (PHI) is integral to the success of clinical research. Although clinical researchers generally understand the need for PHI protection,
“People are experts in everyday living. Physicians are experts in clinical care. Technologies bring them together.” – Patricia Brennan, RN, Ph.D., FAAN, FACMI1 As clinical
The narrative around patient engagement in clinical trials has remained largely unchanged in the last few decades. An alarming number of studies fail to meet
Keeping patients enrolled and active in clinical research is one of the biggest obstacles to study success. But increased protocol complexity and rising costs make
Long before the global pandemic, clinical trial sponsors were consumed with accelerating their studies and improving the trial experience for key stakeholders. Decentralization emerged as
Collecting patient data is a necessary and critical step in clinical research. When done well, it can be fundamental in determining the safety and efficacy
It’s no secret that getting new drugs or biological products approved by the FDA is a challenging task. The low rates at which drugs make
Planned and unplanned mid-study changes add an average of 30 days to clinical trial timelines, according to a new study by the Tufts Center for
Technology continues to play a larger and more critical role in advancing clinical research. It has also brought challenges as regulatory bodies try to establish
The intersection of technology and healthcare has major implications, ranging from encouraging to ominous, for innumerable interested parties. Technological innovators and enthusiastic adoptees tout the
According to a 2019 CISCRP study, 85% of the general public are willing to participate in clinical trial research. Yet, recruitment continues to plague the
The cost of clinical trials continues to rise as studies grow in complexity. A 2014 study by the Tufts Center for the Study of Drug
Developing a successful clinical trial supply chain relies on accurate forecasting. To understand which design elements and functionality are necessary to achieve your study goals,
The increasing complexity of clinical study designs and unique treatment scenarios are making the randomization process for clinical trials more complicated. In fact, a Tufts
To my mom, sister, father-in-law, and late aunt, I promise this: The 2020s will be a breakthrough decade for oncology. For me, cancer isn’t some
COVID-19 isn’t one tragedy, but many. An underreported tragedy is the outsized harm done to communities of color.In New York City — an early COVID-19
Long before COVID-19, recruiting and retaining patients for clinical trials was a growing problem with 85% of all trials failing to recruit enough patients and
As the COVID-19 pandemic first entered the states, the U.S. Food and Drug Administration (FDA) quickly recognized that the public health emergency would disrupt the
Patient centricity is on the rise, and oncology trials have led the charge in that department. It could be said that decentralization is necessary for
Adaptive clinical trial design in oncology research represents an intersection of two major industry trends. One of these is the current prevalence of cancer clinical
When most people think of clinical research in the Asia-Pacific (APAC), India and China are likely the first to come to mind. With the increasing
There’s no denying it: precision oncology holds great promise for the future of cancer treatment. The relatively new practice of targeting specific genetic biomarkers to
In the world of clinical trials, uniformity can be a dirty word. From blind use of placebos to dosage variation, incorporation of variables is an
And we likely won’t be putting the genie back in the bottle. When the pandemic hit the U.S. early this year and the first lockdowns
Trial Drop Out Rates Continue to Increase Trial drop-out rates continue to increase and some clinical trials grind to a halt due to low recruitment
From eClinical data collection to telehealth to wearables and beyond, the clinical trials industry has seen a mass of technological advances over the past decade.
The clinical trial landscape is ever-changing. New technology and innovation have changed the way we look at clinical trial design. While we can agree that
Modern clinical trials can be sprawling networks of clinics, people, and data. They can span borders and oceans. They utilize various communication channels. And they
We comment a lot, on this blog, on the trends influencing the direction of clinical research and the eClinical technology industry. One trend that has
At the onset of COVID-19, we began an impact survey to gauge how sponsors and CROs were reacting to the pandemic and how their trials
Over the past 10 years, the clinical trial industry has transformed dramatically. Globalization has taken off, giving rise to Contract Resource Organization (CRO) outsourcing, decentralized
EDC Pricing Norms Are Murky Today, Electronic Data Capture (EDC) can take many forms. Just as different solutions offer different levels of functionality, there’s also
With the onset of COVID-19, sponsors and CROs are actively looking for ways to continue non-COVID-19 trials that have been left in a standstill due
The symbiotic relationship between dogs and humans spans thousands of years. According to the Smithsonian, dogs were the first domesticated animal and likely have been
As the clinical trial industry focuses on finding a “new normal” during the COVID-19 pandemic, we are focused on how Medrio can assist in your
Regulators and many in the clinical research industry emphasize patient diversity, but how do contract research organizations (CROs) and sponsors achieve it? The US Food
What eClinical features do onology researchers need? According to a new analysis, oncology will account for the majority of clinical trials launched and completed in
With so much riding on the outcome of your research, you want to have reliable eClinical customer service behind you. When evaluating eClinical service providers,
Harnessing technology standard in other highly regulated industries, decentralized trials are gaining traction and becoming a more significant part of our industry. They’re not a
Traditional clinical trial models place limitations on patients, with logistical and geographic barriers making it difficult to recruit, enroll, and retain a diverse participant pool.
In our webinar, Medrio Founder, Mike Novotny, and Covance Vice President and Global Head of Hybrid and Virtual Trials, Bola Oyegunwa, shared in-depth insight into
There’s no question that patient recruitment, adherence, and retention are core concerns for researchers. A recent report cited there are now 40 million patients needed
Digital technology is now completely intertwined with our lives. It’s transformed the way we communicate personally and professionally and has revolutionized industries from business to
What Is eSource? Source data is the initial data recording, and eSource is any source data that is recorded electronically with the goal of producing
Clinical researchers deserve a lot of credit. Bringing a new medical product to market today means navigating a whole host of challenges, from patient recruitment
Lise Lindquist is a Clinical Data Manager at QT Ultrasound, a company using Medrio to collect critical data to support their clinical research and product
It’s no secret that patient recruitment and retention remain among the most significant hurdles in clinical trials. As research becomes more globalized and sophisticated, many
The stakes are high: large risks and the potential for huge rewards are deeply rooted in pharmaceutical research and development. Each year billions are spent
Imagine, for a moment, you’re a data manager overseeing a Phase I study. Your endpoints are set, your database built and deployed, and your data
Early in my career, I built custom databases for whoever needed them. It was the mid-90s when it was a big deal to get a
Statistics suggest that Phase I clinical trials, while by no means free of challenges, are more manageable than later phases. They tend to take less
With MDR right around the corner, organizations conducting medical device clinical research are working overtime to prepare for the massive regulatory shifts about to go
Anyone with more than a few years’ experience in the clinical research industry has been witness to major industry shifts, both in the way clinical
Patient engagement isn’t just a buzzword anymore. With the massive transformation that clinical trials have gone through over recent years, it has emerged at the
If you know Medrio — if you’ve interacted with us at industry conferences, perused our site, or spend a good amount of time on this
When we talk to people who are new to our industry, one of the toughest things for them to wrap their heads around is the
Anyone with an involvement or interest in clinical research is likely to be aware of the challenges sponsors face in getting their compounds approved by
Let’s say you’ve gone through a rigorous selection process to pick your EDC, deployed it, and are ready to train your staff. Your data management
At long last, the eClinical industry is showing signs of evolving beyond the challenges that stem from traditional pricing models and workflows. Here’s a scenario you may
Subscribe To Our Newsletter